restrictions that govern the specificity of CTL to virally infected syngeneic cells or to cells bearing minor histocompatibility antigens are not dictated by the genome of the responding cell but rather by the environment where the cell differentiated and, in the studies of Zinkernagel et al. (6, 7) , by the H-2 antigens of the thymus graft.
The system described in the accompanying paper (4) , where the Ir genecontrolled cross-reactive primary CTL response to TNP-modified syngeneic cells was investigated, is well suited to study the role of the host H-2 antigens on the fine specificity of the T-cell clones that develop during differentiation. Taking into account that primary CTL induced to TNP-modified syngeneic cells from C3H (H-2 k) mice are unable to lyse TNP-modified allogeneic targets, bone marrow cells from "nonresponder" C3H mice were allowed to differentiate in lethally iradiated ~'responder" (B6 × C3H)F1 (H-2 b~k) recipients. The ability of these chimeric C3H cells [C3H -~ (B6 × C3H)F1] to display cross-reactive lysis after primary stimulation with TNP-modified C3H cells was assessed. The C3H (H-2 k) CTL which differentiated in a (B6 × C3H)F1 environment shared similar levels of cross-reactive lysis as the (B6 × C3H)F1 CTL, demonstrating the effect of the environment where T cells differentiate on the specificity of the primary CTL response to TNP-modified MHC antigens.
Materials and Methods
Mice. 6-to 12-wk-old male mice were used in this study. C57BL/6 (B6), H-2b; BALB/c, H-2d; C3H/HeJ, H-2k; DBAJl, H-2q; and (B6 x C3H)F1, H-2 blk hybrid mice were obtained from The Jackson Laboratory (Bar Harbor, Maine).
Preparation of Chimeras. The general method of Sprent et al. (8) was followed. Bone marrow cells were isolated from B6, C3H, and (B6 × C3H)F1 mice and washed several times. They were then treated twice with anti-Thy 1.2 antiserum and rabbit complement. 1.5 x 107 treated B6, C3H, or (B6 x C3H)FI bone marrow cells were then injected i.v. into lethally X-irradiated (675 R)(B6 x C3H)F~ hybrid mice. All irradiated mice receiving no bone marrow cells died within 1 wk. F~ recipient animals were isolated 2 days before irradiation and maintained on antibiotics (Neosperin; Burroughs Wellcome Co., Research Triangle Park, N. C.) for 1 mo after irradiation. Survival was 80-90% in all groups receiving bone marrow cells. Mice were histocompatibility typed and used for study 12-16 wk after irradiation.
H-2 Typing. Spleen cells from each radiation chimera were tissue typed by the microcytotoxicity assay (9) (B6 x C3H)FI radiation chimeras was <2% (which equals the lysis obtained with normal mouse serum in controls).
Mixed Lymphocyte Culture (MLC). 5 × 105 respender spleen cells were cultured in fiatbottomed microtiter wells (Linbro Chemical Co., New Haven, Conn.) in the presence of 10 e irradiated (1,500 R) splenic stimulator cells. Cells were cultured in RPMI 1640 medium supplemental with 0.5% normal mouse serum, 2 mM glutamine, 100 U/ml of penicillin, 100 /~g/ml streptomycin, and 5 x 10 -5 M 2-mercaptoethanol. After 48 h cells were pulsed for 6 h with 0.25 ml of a solution containing [3H]thymidine (40 mCi/ml). Acid-precipitable DNA was isolated and incorporated counts measured on a Beckman liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.).
CTL Induction and the 5~Cr Release Assay. Induction of CTL to allogeneic or TNP-medified syngeneic cells, the 51Cr release assay, and statistical methods are described in the preceding report (4) . In some experiments, CTL effectors were treated with anti-H-2 antiserum and complement before incubation with 5~Cr-labeled target cells. They were incubated for 45 rain at room temperature with specific anti-H-2 antiserum, washed, and then incubated for 45 min at 37°C with a 1:5 dilution of preselected rabbit complement. Cells were then washed several times in DNase containing media, counted, and diluted appropriately. The specificity and concentration of antisera and complement that were used are listed in Table IV . Conditions used for antiserum plus complement lysis yielded >95% lysis of appropriate targets as measured by dye exclusion. 
Results

MLC Responses of Normal and Chimeric Lymphoid Cells.
CTL Responsiveness of Normal and Chimeric Spleen Cells. Normal C3H
spleen cells can be induced by allogeneic cells to lyse H-2 b or H-2 d tumor or normal spleen targets; however, chimeric C3H --* (B6 × C3H)F1 spleen cells do not lyse H-2 b targets while lysing H-2 d targets well (Table II) . Though unable to respond to H-2 b stimulator cells, the chimeric C3H cells were able to respond to TNP-modified B6 stimulator cells. Chimeric C3H cells also responded to TNP-modified C3H cells.
Cross-Reactive Lysis by CTL from Normal and Chimeric Mice.
We next asked whether the ability to lyse TNP-modified allogeneic targets after stimulation with TNP-modified syngeneic cells was altered in the C3H --* (B6 × C3H)F1 chimeric mice. Results shown in Table III demonstrate, as in the preceding report (4) , that normal C3H CTL induced by TNP-modified syngeneic cells only lyse TNP-ceupled syngeneic cells, i.e. they do not demonstrate crossreactive lysis on TNP-coupled allogeneic cells.
When C3H --* (B6 × C3H)F~ spleen cells are stimulated by TNP-modified C3H spleen cells, CTL are produced that lyse TNP-ceupled syngeneic (C3H) and small number of residual (B6 × C3H)F1 CTL could explain the cross-reactive lysis produced in C3H --~ (B6 × C3H)F1 chimeric mice. Results in Table IV demonstrate that anti-H-2 b antiserum plus complement treatment, although it removes 100% of the B6 CTL which lyse TNP-coupled allogeneic targets after TNP-modified B6 spleen-cell stimulation, does not affect the cross-reactive lysis produced by C3H --* (B6 × C3H)F1 CTL induced by TNP-modified C3H stimulators. Anti-H-T antiserum plus complement treatment completely eliminates functional cross-reactive CTL from the chimeric CTL population. When these data are considered along with the H-2 typing data, showing that >98% of all spleen cells from C3H -~ (B6 × C3H)F1 mice bear H-2 k antigens before CTL induction, it is clear that the cross-reactive lysis seen when C3H --* (B6 × C3H)FI spleen cells are induced by TNP-modified C3H stimulators is due to CTL of C3H origin, and not to contaminating F1 cells.
Discussion
Bone marrow cells from H-2 k C3H mice have been allowed to mature in an irradiated (H-2 b~k) (B6 × C3H)FI recipient. Spleen cells from these chimeric mice, which were of C3H origin, were found to be tolerant to B6 alloantigen in beth the mixed lymphocyte reaction and by cell-mediated cytotoxicity. These chimeric spleen cells when stimulated in vitro with TNP-modified syngeneic cells now demonstrated cross-reactive lysis of TNP-modified allogeneic targets (i.e. TNP-BALB/c, TNP-DBA/1, and TNP-B6 targets). The effector cells exhibiting cross-reactive lysis were only susceptible to lysis by anti-H-2 k antiserum plus complement and were unaffected by anti-H-2 b antiserum plus complement treatment; thus eliminating any role for contaminating FI effector cells.
The data therefore demonstrate that the pattern of CTL responsiveness generated by primary immunization with TNP-modified syngeneic cells can be altered by the environment in which the T cell differentiated. In these experiments, C3H T cells, which normally are unable to exhibit cross-reactive lysis after primary in vitro immunization with TNP-modified syngeneic cells, exhibit the cross-reactive phenotype if they differentiated in a host that does exhibit cross-reactive lysis.
These findings are in agreement with recent observations of Zinkernagel et al. (6, 7) and Bevan (5). Zinkernagel et al. demonstrated that T cells from radiation chimeras develop virus-specific CTL only when presented with virally infected cells that carry the H-2 antigens of the irradiated recipients. From studies with thymus grafts, Zinkernagel et al. (6, 7) were able to conclude that the radioresistant portion of the thymus bears the H-2 antigens involved in restricting virus-specific killer T-cell precursors. Though the influence of the chimeric host on the specificity of CTL to TNP-modified syngeneic antigens is quite apparent from our studies, we cannot conclude that this effect is due to the host thymus without further studies involving thymic transplants.
Inasmuch as macrophages have been demonstrated to be involved in the induction of immune responses in many systems (10) , the possibility that residual (B6 × C3H)F1 macrophages are responsible for our results must be entertained. It is unlikely, however, that this is the case. Zinkernagel et al. (7) demonstrated that, in long-term irradiation bone marrow chimeras, the lymphoreticular system had been replaced by cells derived from the reconstituting stem cells. In fact, Zinkernagel was required to adoptively transfer chimeric spleen cells into a recently irradiated recipient and then virally infect in order to utilize the host lymphoreticular system for viral antigen presentation. Because we waited 3-4 mo before testing our radiation chimeras, it is unlikely that FI macrophages continued to populate the spleen.
Our results could also be explained by loss of a regulatory cell that normally restricts the response to C3H CTL, i.e. suppressing cross-reactive lysis. It could be argued that C3H bone marrow cells developing in a (B6 × C3H)F~ environment lose these clones of regulatory cells. However, attempts at demonstrating such a regulatory cell so far have been unsuccessful; specifically, treatment of C3H mice with cyclophosphamide or adult thymectomy does not appear to reverse the H-2 restriction (data not shown).
It is still not clear how the host environment, presumably the H-2 antigens of the thymus, influences T-cell maturation to produce the phenotypic response pattern characteristic of the adult animal. Jerne (11) originally proposed that the earliest antigen receptors expressed on lymphocytes are specific for self-H-2 antigens. Precursors of CTL presumably express receptors for self-H-2K and H-2D, and proliferate in the thymic environment in response to these MHC products. During this proliferation, the receptors of these CTL precursors are postulated to undergo either selectional and]or mutational changes, ultimately yielding the fully mature receptor pool with preferential specificity for slight variants of the original self-MHC products as discussed previously (12) (13) (14) (15) (16) . Although not fully documented, this hypothesis can explain beth the underlying basis for the hierarchy of allogeneic, xenogeneic, and modified self-responses, as well as the responses of chimeric mice to modified self-antigens. Furthermore, this model may have important implications for humoral or DTH-type responses for which responder status is regulated by I region genes. It is still an open issue whether some types of Ir gene control are expressed directly in the T cell or indirectly by I region genes in the thymus, affecting the differentiation of Tcell precursors in a manner similar to H-2K and H-2D for CTL. This latter mechanism may in some cases be interpreted as Ir gene expression in the macrophages or B cells with which the T cell must interact via antigen and Ia. However, we favor the alternative that in many instances Ia antigens themselves on macrophages and/or B cells control T-cell antigen recognition independently of receptor repertoire regulation in the thymus. These issues, which pertain to both K-, D-, and I-restricted responses, remain to be resolved by a combination of the current approach using chimeras and careful cell separation and mixing experiments to define the cell(s) involved in the altered response pattern of lymphocytes whose precursors have differentiated in a "nonself" environment.
Summary
Bone marrow cells from C3H (H-2 k) mice, a strain that does not exhibit crossreactive lysis of trinitrophenyl (TNP)-modified allogeneic targets, were allowed to mature in heavily irradiated (B6 × C3H)FI (H-2 b/k) recipients, an F1 hybrid that does demonstrate cross-reactive lysis. Spleen cells from these chimeric mice were removed after 3-4 mo and by H-2 typing shown to be of C3H origin. These cells were found to be tolerant to B6 alloantigens by mixed lymphocyte reaction and cell-mediated cytotoxicity and, when stimulated in vitro with TNP-modifled syngeneic cells, now cross-reactively lysed TNP-modified allogeneic targets. These studies demonstrate that the host environment where T cells differentiate influences the specificity of the primary cytolytic T-lymphocyte (CTL) response to TNP-modified syngeneic antigens.
